FDA panel backs ketamine-like drug for depression

An expert panel for the U.S. Food and Drug Administration has endorsed a drug for major depressive disorder that is a close relative to ketamine. If approved by the FDA, the new drug known as esketamine would be available to patients who have not found relief with at least two other antidepressants. The Tuesday vote … Read more